ArticleFood science & nutrition2025
Identification of Soy-Derived Peptides With Micelle Disruption Activity of Secondary Bile Acids.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanism-First Psychobiotics: Fermented Vegetables, Dairy, and Soy for Depression and Anxiety.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bile acids, which originate in the liver as primary bile acids, facilitate the absorption of lipophilic components into the intestines and exist as micellar structures. Intestinal bacteria convert primary bile acids to secondary bile acids, such as deoxycholic acid (DCA), which is associated with colorectal cancer. Therefore, their elimination from the body is preferred. Soy protein hydrolysates are known for their bile acid-binding properties, which prompted our investigation of DCA-specific binding and micelle-disrupting peptides. We designed a peptide library from eight soy protein sequences and selected 42 candidate peptides based on their DCA-binding activity. These peptides were synthesized, and their ability to disrupt bile acid micelles was assessed using a 96-well high-throughput assay system. Of the 42 peptides evaluated, 41 exhibited significant DCA micelle degradation, and 21 showed specific activity only for DCA micelles. Further research involved preparing soy protein pepsin hydrolysates and identifying 1,354 free peptides. Among these, 10 peptides containing sequences from the initial peptide library were identified. All peptides exhibited DCA micelle-disrupting activity. These peptides are believed to facilitate the excretion of secondary bile acids. Notably, FGSLRKNAM and SLRKNAM selectively disrupted DCA micelles without affecting the micelles of other bile acids. As these two peptides were also identified in the undigested high molecular weight fraction, they are considered key peptides with high potential for efficiently promoting the excretion of DCA.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.